Francis Mhimbira

In the News

Scientists: Target TB interventions on these transmission hotspots

(Dar es Salaam, September 14, 2017). Scientists at Ifakara Health Institute (IHI) have recently adapted a method for identifying tuberculosis (TB) transmission hotpots using a new technique that could revolutionize …

Research Office, Lab Technicians required

IHI is looking for suitably qualified Research Officer and Laboratory Technicians to fill vacant positions in the Laboratory Unit in Bagamoyo. To apply or share, get more details about these …

Recent Projects

Understanding and enhancing approaches to quality improvement in small and medium sized private facilities in sub-Saharan Africa

This is an evaluation study that IHI is conducting in collaboration with London school of hygiene and tropical medicine. The research takes place in the context of an innovative intervention …

Vaccine Delivery Costing Study

As countries drive towards achieving high and equitable coverage of life-saving vaccines, the availability of sustainable, equitable, and predictable financing for vaccine delivery is essential. Over the last two decades, …

Francis Mhimbira

Research Scientist and Head of Interventions & Clinical Trials

Dr. Francis Mhimbira is an epidemiologist and a research scientist based at Ifakara Health Institute. Dr. Mhimbira received his medical degree at Muhimbili University College of Health Sciences (MUCHS), Tanzania, and did a Masters degree in Epidemiology from The University of Melbourne, Australia. He works within the intervention thematic group and conducts research on TB clinical trials for new drugs and vaccines. His work also involves evaluating new TB diagnostic tools and epidemiological studies on TB and co-infections (such as HIV, helminth and respiratory pathogens). Francis also does operational research to improve TB case detection and improve TB treatment outcomes. He is currently a national and principal investigator of Phase III clinical trial (NC-006) of new TB drugs and regimen. Francis is currently the Head of Interventions and Clinical Trials Department.

View Dr. Mhimbira’s Research Interests and Publications

Projects

Evaluation of combinations of bedaquiline, moxifloxacin, PA‐824 and pyrazinamide for treatment of newly-diagnosed TB patients

Evaluation of efficacy, safety and tolerability of a three-drug regimen (Moxifloxacin+PA‐824+Pyrazinamide) for TB and MDR-TB

A PIXELBASE DESIGN
© Ifakara Health Institute (IHI), 2016